Efficacy News and Research

RSS

Eli Lilly trial reveals Alzheimer's drug that significantly slows cognitive decline

Study examined the safety and efficacy of the study drug donanemab in participants with early Alzheimer's disease (AD).

4 May 2023

Colorado becomes the first state to ban so-called abortion pill reversals

In Glenwood Springs, Colorado, registered nurse Katie Laven answers calls from people who've started the two-pill medication abortion regimen and want to stop the process.

4 May 2023

Advancing the development of vaccines through recombinant technology

In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO at Sino Biological, about current developments in the field of vaccine development through recombinant techniques.

From Sino Biological Inc. 4 May 2023

COVID-19 risk: natural immunity vs. vaccine induced immunity

Researchers evaluated the immune protection conferred by previous SARS-CoV-2 infection and/or COVID-19 vaccines.

4 May 2023

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

From Gyros Protein Technologies AB 4 May 2023

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection

A retrospective cohort study comparing the clinical presentation and treatment outcomes of people with HIV and those without HIV who were treated with tecovirimat for confirmed mpox virus infection. The study found that HIV status did not seem to affect treatment outcomes.

4 May 2023

Revving up COVID mRNA vaccines: Algorithm generates 128-fold increase in antibodies

Research paper proposes a new method for predicting highly expressed genes based on codon usage bias and minimum free energy of mRNA secondary structures. The method involves constructing a stochastic grammar that generates sequences with high CAI and low MFE, and testing it on two mRNA vaccines.

3 May 2023

Study finds small but positive impact of school-based interventions on childhood obesity

Researcher paper is an update of a Cochrane systematic review on childhood obesity prevention interventions. It includes randomized controlled trials published until June 2021 that assess the effectiveness, adverse effects, and cost-effectiveness of interventions on the weight of children aged 6-18 years.

3 May 2023

Researchers report positive results from Phase 2 clinical trial of investigational treatment against long COVID fatigue

Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue.

3 May 2023

In the first 6 months after a stroke, is there an association between physical activity trajectories and functional recovery?

Researchers examined the association between physical activity in stroke patients and functional recovery.

3 May 2023

Using PandaOmics to identify dual-purpose therapeutic targets to treat aging and glioblastoma

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 8, entitled, "Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform."

3 May 2023

Monovalent mRNA COVID-19 vaccines provide durable protection against critical outcomes

Study reports on the effectiveness of monovalent mRNA vaccination in preventing COVID-19-associated invasive mechanical ventilation and death. In other words, the study looks at how well the mRNA vaccine works in preventing severe illness and death from COVID-19.

2 May 2023

UC San Francisco will be first hospital in California to offer pharmacogenetic testing

Beginning May 9, UC San Francisco will be the first hospital in California, and one of only a few nationwide, to offer pharmacogenetic testing.

2 May 2023

New technology can deliver gene therapy directly to the lung

Scientists at UMass Chan Medical School have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease.

2 May 2023

Obesity management: a women's health approach

Researchers provide a women's health perspective on obesity.

1 May 2023

Therapeutic hypothermia for treating neonatal encephalopathy ineffective for some newborns

Therapeutic hypothermia, the only evidence-based treatment for newborns born with neonatal encephalopathy (NE) at or after 36 weeks, is not effective for reducing death or moderate/severe disability in newborns born between 33 and 35 weeks, according to a new study.

28 Apr 2023

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Research reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years. The study found that the vaccine was safe, immunogenic, and efficacious in preventing COVID-19, including the Delta variant, in adolescents.

27 Apr 2023

Efficacy News and Research

Eli Lilly trial reveals Alzheimer's drug that significantly slows cognitive decline

Colorado becomes the first state to ban so-called abortion pill reversals

Advancing the development of vaccines through recombinant technology

COVID-19 risk: natural immunity vs. vaccine induced immunity

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection

Revving up COVID mRNA vaccines: Algorithm generates 128-fold increase in antibodies

Study finds small but positive impact of school-based interventions on childhood obesity

Researchers report positive results from Phase 2 clinical trial of investigational treatment against long COVID fatigue

In the first 6 months after a stroke, is there an association between physical activity trajectories and functional recovery?

Using PandaOmics to identify dual-purpose therapeutic targets to treat aging and glioblastoma

Monovalent mRNA COVID-19 vaccines provide durable protection against critical outcomes

UC San Francisco will be first hospital in California to offer pharmacogenetic testing

New technology can deliver gene therapy directly to the lung

Obesity management: a women's health approach

Therapeutic hypothermia for treating neonatal encephalopathy ineffective for some newborns

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Fecal microbiota transplant: Effective solution for recurrent C. difficile infections

Molnupiravir treatment reduces risk of long COVID in high risk patients

Healthy eating lowers risk of sleep apnea

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News